Program | Discovery | Lead Optimization | IND-Enabling | Phase 1 | Phase 2 | Phase 3 | Partner |
---|---|---|---|---|---|---|---|
PRA023 - Anti-TL1A mAb | |||||||
PR600 - Anti-TNF Super Family Member mAb | |||||||
PR300 - GPCR Modulator Small Molecule | |||||||
TPR15 - mAb | Partnered | ||||||
Prometheus has an early-stage discovery collaboration with Takeda Pharmaceuticals. |
Program | Progress |
---|---|
PRA023 | Phase 1 |
PR600 | Discovery |
PR300 | Discovery |
TPR15 | Discovery |